Drug Treatment of Neuromyelitis Optica Spectrum Disorders: Out with the Old, in with the New?

Overview of attention for article published in ImmunoTargets and Therapy, March 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 42 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 15 publications that cite this research output.

15

The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.

Review of Satralizumab for Neuromyelitis Optica Spectrum Disorder: A New Biologic Agent Targeting the Interleukin-6 Receptor

Article in Cureus (February 2024)

Therapeutic inertia in the management of neuromyelitis optica spectrum disorder

Article in Frontiers in Neurology (February 2024)

Satralizumab as a treatment for pediatric-onset neuromyelitis optica spectrum disorder with cluster attack: a case report

Article in Journal of Neurology (May 2023)